β-Arrestin and receptor tyrosine kinases in non-small cell lung cancer: A comprehensive review
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of biological macromolecules
- Publicado em
- 19 mar 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
β-Arrestin and receptor tyrosine kinases in non-small cell lung cancer: A comprehensive review
Rima Paul, Dhiman Chandra Paul
Descritores MeSH
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Receptor Protein-Tyrosine Kinases
- beta-Arrestins
- Signal Transduction
- Molecular Targeted Therapy
- Animals
- Antineoplastic Agents
- Humans
Veja também
Estudos relacionados
- EML4-ALK in Non-small Cell Lung Cancer: Molecular Mechanisms and Targeted Therapies
- Comparison of treatment efficacy of targeted therapies approved in China for non-small cell lung cancer before and after the introduction of accelerated drug marketing registration procedures
- Correlation between ALK+ non-small cell lung cancer targeted therapy and thrombosis: a systematic review and network meta-analysis
- Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment